USPTO serial 79133404
NICOX
Reviewed by CopyMark Law Group
Reg. 4582232Status 709
- Filing date
- Status date
- Registration date
- Aug 12, 2014
- Examiner
- MORENO, PAUL A
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NICOX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Valbonne, FR
Valbonne, FR
Valbonne, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Zaccaria
John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of ocular and ophthalmological diseases; respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Dietetic foods adapted for medical use, namely, meal replacement bars, meal replacement drink mixes, minerals, vitamins ] | SECTION 71 - CANCELLED | — |
| 010 | [ Medical apparatus and instruments for use in the treatment of ocular and ophthalmological disease, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous systems disease, musculoskeletal systems disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns; Diagnostic apparatus for medical purposes for detecting ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, burns ] | SECTION 71 - CANCELLED | — |
| 035 | [ Online retail and wholesale store services featuring pharmaceutical products, dietary supplements, dietetic substances adapted for medical use, medical apparatus and instruments, and diagnostic apparatus for medical purposes ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific and medical research; analysis and scientific research services in the pharmaceutical field; research services in the pharmaceutical field relative to traceability and quality control of making pharmaceutical products | SECTION 71 - CANCELLED | — |
| 044 | [ Medical evaluation services in the fields of ocular and ophthalmological diseases, respiratory system disease, gastrointestinal system disease, endocrine system disease, cardiovascular system disease, central nervous system disease, peripheral nervous system disease, musculoskeletal system disease, urinary system disease, integumentary system disease, reproductive system disease, skin and scalp disease, cancer, diabetes, thrombosis, arthritis, pain, inflammation, blood disease and disorders, cold, coughs, influenza, vertigo, nausea, vomiting, migraine, mouth and gum disease, and burns, for purposes of guiding treatment ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NICOX SA
- Other trademarks owned by NICOX SA
- Other trademarks owned by NICOX SA
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NICOX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 6, 2026 | C71T | CANCELLED SECTION 71 | — |
| Aug 12, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 12, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Nov 28, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 29, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 29, 2021 | INPC | INVALIDATION PROCESSED | — |
| Oct 3, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 3, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Feb 3, 2021 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Feb 1, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 1, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 9, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 12, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 8, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 23, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 23, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 12, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 12, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 27, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 27, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 23, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 7, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 7, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 7, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 18, 2014 | ALIE | ASSIGNED TO LIE | — |
| Mar 27, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 27, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 27, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 27, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 27, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 22, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 22, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 22, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 11, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 10, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 28, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 28, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 27, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2013 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Aug 9, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 5, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 2, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |